Global Alfacalcidol Soft Capsules Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Alfacalcidol Soft Capsules Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Alfacalcidol Soft Capsules Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 0.25µg
  • 1.2.3 1µg
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Alfacalcidol Soft Capsules Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Adult
  • 1.3.3 Child
  • 1.3.4 Newborn
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Alfacalcidol Soft Capsules Sales Estimates and Forecasts 2019-2030
• 2.2 Global Alfacalcidol Soft Capsules Revenue by Region
  • 2.2.1 Global Alfacalcidol Soft Capsules Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Alfacalcidol Soft Capsules Revenue by Region (2019-2024)
  • 2.2.3 Global Alfacalcidol Soft Capsules Revenue by Region (2025-2030)
  • 2.2.4 Global Alfacalcidol Soft Capsules Revenue Market Share by Region (2019-2030)
• 2.3 Global Alfacalcidol Soft Capsules Sales Estimates and Forecasts 2019-2030
• 2.4 Global Alfacalcidol Soft Capsules Sales by Region
  • 2.4.1 Global Alfacalcidol Soft Capsules Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Alfacalcidol Soft Capsules Sales by Region (2019-2024)
  • 2.4.3 Global Alfacalcidol Soft Capsules Sales by Region (2025-2030)
  • 2.4.4 Global Alfacalcidol Soft Capsules Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Alfacalcidol Soft Capsules Sales by Manufacturers
  • 3.1.1 Global Alfacalcidol Soft Capsules Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Alfacalcidol Soft Capsules Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alfacalcidol Soft Capsules in 2023
• 3.2 Global Alfacalcidol Soft Capsules Revenue by Manufacturers
  • 3.2.1 Global Alfacalcidol Soft Capsules Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Alfacalcidol Soft Capsules Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Alfacalcidol Soft Capsules Revenue in 2023
• 3.3 Global Key Players of Alfacalcidol Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
• 3.4 Global Alfacalcidol Soft Capsules Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Alfacalcidol Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Alfacalcidol Soft Capsules, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Alfacalcidol Soft Capsules, Product Offered and Application
• 3.8 Global Key Manufacturers of Alfacalcidol Soft Capsules, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Alfacalcidol Soft Capsules Sales by Type
  • 4.1.1 Global Alfacalcidol Soft Capsules Historical Sales by Type (2019-2024)
  • 4.1.2 Global Alfacalcidol Soft Capsules Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• 4.2 Global Alfacalcidol Soft Capsules Revenue by Type
  • 4.2.1 Global Alfacalcidol Soft Capsules Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Alfacalcidol Soft Capsules Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• 4.3 Global Alfacalcidol Soft Capsules Price by Type
  • 4.3.1 Global Alfacalcidol Soft Capsules Price by Type (2019-2024)
  • 4.3.2 Global Alfacalcidol Soft Capsules Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Alfacalcidol Soft Capsules Sales by Application
  • 5.1.1 Global Alfacalcidol Soft Capsules Historical Sales by Application (2019-2024)
  • 5.1.2 Global Alfacalcidol Soft Capsules Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• 5.2 Global Alfacalcidol Soft Capsules Revenue by Application
  • 5.2.1 Global Alfacalcidol Soft Capsules Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Alfacalcidol Soft Capsules Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• 5.3 Global Alfacalcidol Soft Capsules Price by Application
  • 5.3.1 Global Alfacalcidol Soft Capsules Price by Application (2019-2024)
  • 5.3.2 Global Alfacalcidol Soft Capsules Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Alfacalcidol Soft Capsules Market Size by Type
  • 6.1.1 US & Canada Alfacalcidol Soft Capsules Sales by Type (2019-2030)
  • 6.1.2 US & Canada Alfacalcidol Soft Capsules Revenue by Type (2019-2030)
• 6.2 US & Canada Alfacalcidol Soft Capsules Market Size by Application
  • 6.2.1 US & Canada Alfacalcidol Soft Capsules Sales by Application (2019-2030)
  • 6.2.2 US & Canada Alfacalcidol Soft Capsules Revenue by Application (2019-2030)
• 6.3 US & Canada Alfacalcidol Soft Capsules Market Size by Country
  • 6.3.1 US & Canada Alfacalcidol Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Alfacalcidol Soft Capsules Sales by Country (2019-2030)
  • 6.3.3 US & Canada Alfacalcidol Soft Capsules Revenue by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Alfacalcidol Soft Capsules Market Size by Type
  • 7.1.1 Europe Alfacalcidol Soft Capsules Sales by Type (2019-2030)
  • 7.1.2 Europe Alfacalcidol Soft Capsules Revenue by Type (2019-2030)
• 7.2 Europe Alfacalcidol Soft Capsules Market Size by Application
  • 7.2.1 Europe Alfacalcidol Soft Capsules Sales by Application (2019-2030)
  • 7.2.2 Europe Alfacalcidol Soft Capsules Revenue by Application (2019-2030)
• 7.3 Europe Alfacalcidol Soft Capsules Market Size by Country
  • 7.3.1 Europe Alfacalcidol Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Alfacalcidol Soft Capsules Sales by Country (2019-2030)
  • 7.3.3 Europe Alfacalcidol Soft Capsules Revenue by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Netherlands

8 China

• 8.1 China Alfacalcidol Soft Capsules Market Size
  • 8.1.1 China Alfacalcidol Soft Capsules Sales (2019-2030)
  • 8.1.2 China Alfacalcidol Soft Capsules Revenue (2019-2030)
• 8.2 China Alfacalcidol Soft Capsules Market Size by Application
  • 8.2.1 China Alfacalcidol Soft Capsules Sales by Application (2019-2030)
  • 8.2.2 China Alfacalcidol Soft Capsules Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Alfacalcidol Soft Capsules Market Size by Type
  • 9.1.1 Asia Alfacalcidol Soft Capsules Sales by Type (2019-2030)
  • 9.1.2 Asia Alfacalcidol Soft Capsules Revenue by Type (2019-2030)
• 9.2 Asia Alfacalcidol Soft Capsules Market Size by Application
  • 9.2.1 Asia Alfacalcidol Soft Capsules Sales by Application (2019-2030)
  • 9.2.2 Asia Alfacalcidol Soft Capsules Revenue by Application (2019-2030)
• 9.3 Asia Alfacalcidol Soft Capsules Sales by Region
  • 9.3.1 Asia Alfacalcidol Soft Capsules Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Alfacalcidol Soft Capsules Revenue by Region (2019-2030)
  • 9.3.3 Asia Alfacalcidol Soft Capsules Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 LEO Pharmaceutical
  • 11.1.1 LEO Pharmaceutical Company Information
  • 11.1.2 LEO Pharmaceutical Overview
  • 11.1.3 LEO Pharmaceutical Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 LEO Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 LEO Pharmaceutical Recent Developments
• 11.2 Teva Pharmaceutical
  • 11.2.1 Teva Pharmaceutical Company Information
  • 11.2.2 Teva Pharmaceutical Overview
  • 11.2.3 Teva Pharmaceutical Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Teva Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Teva Pharmaceutical Recent Developments
• 11.3 Teijin Pharma
  • 11.3.1 Teijin Pharma Company Information
  • 11.3.2 Teijin Pharma Overview
  • 11.3.3 Teijin Pharma Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Teijin Pharma Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Teijin Pharma Recent Developments
• 11.4 Lupin
  • 11.4.1 Lupin Company Information
  • 11.4.2 Lupin Overview
  • 11.4.3 Lupin Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Lupin Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Lupin Recent Developments
• 11.5 Nantong Huashan Pharmaceutical
  • 11.5.1 Nantong Huashan Pharmaceutical Company Information
  • 11.5.2 Nantong Huashan Pharmaceutical Overview
  • 11.5.3 Nantong Huashan Pharmaceutical Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Nantong Huashan Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Nantong Huashan Pharmaceutical Recent Developments
• 11.6 Xingqun Pharmaceutical
  • 11.6.1 Xingqun Pharmaceutical Company Information
  • 11.6.2 Xingqun Pharmaceutical Overview
  • 11.6.3 Xingqun Pharmaceutical Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Xingqun Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Xingqun Pharmaceutical Recent Developments
• 11.7 Shanghai Sine Pharmaceutical
  • 11.7.1 Shanghai Sine Pharmaceutical Company Information
  • 11.7.2 Shanghai Sine Pharmaceutical Overview
  • 11.7.3 Shanghai Sine Pharmaceutical Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Shanghai Sine Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Shanghai Sine Pharmaceutical Recent Developments
• 11.8 CP Pharmaceutical Qingdao
  • 11.8.1 CP Pharmaceutical Qingdao Company Information
  • 11.8.2 CP Pharmaceutical Qingdao Overview
  • 11.8.3 CP Pharmaceutical Qingdao Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 CP Pharmaceutical Qingdao Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 CP Pharmaceutical Qingdao Recent Developments
• 11.9 China Res Double-Crane
  • 11.9.1 China Res Double-Crane Company Information
  • 11.9.2 China Res Double-Crane Overview
  • 11.9.3 China Res Double-Crane Alfacalcidol Soft Capsules Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 China Res Double-Crane Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 China Res Double-Crane Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Alfacalcidol Soft Capsules Industry Chain Analysis
• 12.2 Alfacalcidol Soft Capsules Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Alfacalcidol Soft Capsules Production Mode & Process
• 12.4 Alfacalcidol Soft Capsules Sales and Marketing
  • 12.4.1 Alfacalcidol Soft Capsules Sales Channels
  • 12.4.2 Alfacalcidol Soft Capsules Distributors
• 12.5 Alfacalcidol Soft Capsules Customers

13 Market Dynamics

• 13.1 Alfacalcidol Soft Capsules Industry Trends
• 13.2 Alfacalcidol Soft Capsules Market Drivers
• 13.3 Alfacalcidol Soft Capsules Market Challenges
• 13.4 Alfacalcidol Soft Capsules Market Restraints

14 Key Findings in The Global Alfacalcidol Soft Capsules Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Alfacalcidol Soft Capsules Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Table 2. Major Manufacturers of 0.25µg
• Table 3. Major Manufacturers of 1µg
• Table 4. Major Manufacturers of Others
• Table 5. Global Alfacalcidol Soft Capsules Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Table 6. Global Alfacalcidol Soft Capsules Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 7. Global Alfacalcidol Soft Capsules Revenue by Region (2019-2024) & (US$ Million)
• Table 8. Global Alfacalcidol Soft Capsules Revenue by Region (2025-2030) & (US$ Million)
• Table 9. Global Alfacalcidol Soft Capsules Revenue Market Share by Region (2019-2024)
• Table 10. Global Alfacalcidol Soft Capsules Revenue Market Share by Region (2025-2030)
• Table 11. Global Alfacalcidol Soft Capsules Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 12. Global Alfacalcidol Soft Capsules Sales by Region (2019-2024) & (K Units)
• Table 13. Global Alfacalcidol Soft Capsules Sales by Region (2025-2030) & (K Units)
• Table 14. Global Alfacalcidol Soft Capsules Sales Market Share by Region (2019-2024)
• Table 15. Global Alfacalcidol Soft Capsules Sales Market Share by Region (2025-2030)
• Table 16. Global Alfacalcidol Soft Capsules Sales by Manufacturers (2019-2024) & (K Units)
• Table 17. Global Alfacalcidol Soft Capsules Sales Share by Manufacturers (2019-2024)
• Table 18. Global Alfacalcidol Soft Capsules Revenue by Manufacturers (2019-2024) & (US$ Million)
• Table 19. Global Alfacalcidol Soft Capsules Revenue Share by Manufacturers (2019-2024)
• Table 20. Global Key Players of Alfacalcidol Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
• Table 21. Alfacalcidol Soft Capsules Price by Manufacturers 2019-2024 (US$/Unit)
• Table 22. Global Alfacalcidol Soft Capsules Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Alfacalcidol Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alfacalcidol Soft Capsules as of 2023)
• Table 24. Global Key Manufacturers of Alfacalcidol Soft Capsules, Manufacturing Base Distribution and Headquarters
• Table 25. Global Key Manufacturers of Alfacalcidol Soft Capsules, Product Offered and Application
• Table 26. Global Key Manufacturers of Alfacalcidol Soft Capsules, Date of Enter into This Industry
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Alfacalcidol Soft Capsules Sales by Type (2019-2024) & (K Units)
• Table 29. Global Alfacalcidol Soft Capsules Sales by Type (2025-2030) & (K Units)
• Table 30. Global Alfacalcidol Soft Capsules Sales Share by Type (2019-2024)
• Table 31. Global Alfacalcidol Soft Capsules Sales Share by Type (2025-2030)
• Table 32. Global Alfacalcidol Soft Capsules Revenue by Type (2019-2024) & (US$ Million)
• Table 33. Global Alfacalcidol Soft Capsules Revenue by Type (2025-2030) & (US$ Million)
• Table 34. Global Alfacalcidol Soft Capsules Revenue Share by Type (2019-2024)
• Table 35. Global Alfacalcidol Soft Capsules Revenue Share by Type (2025-2030)
• Table 36. Alfacalcidol Soft Capsules Price by Type (2019-2024) & (US$/Unit)
• Table 37. Global Alfacalcidol Soft Capsules Price Forecast by Type (2025-2030) & (US$/Unit)
• Table 38. Global Alfacalcidol Soft Capsules Sales by Application (2019-2024) & (K Units)
• Table 39. Global Alfacalcidol Soft Capsules Sales by Application (2025-2030) & (K Units)
• Table 40. Global Alfacalcidol Soft Capsules Sales Share by Application (2019-2024)
• Table 41. Global Alfacalcidol Soft Capsules Sales Share by Application (2025-2030)
• Table 42. Global Alfacalcidol Soft Capsules Revenue by Application (2019-2024) & (US$ Million)
• Table 43. Global Alfacalcidol Soft Capsules Revenue by Application (2025-2030) & (US$ Million)
• Table 44. Global Alfacalcidol Soft Capsules Revenue Share by Application (2019-2024)
• Table 45. Global Alfacalcidol Soft Capsules Revenue Share by Application (2025-2030)
• Table 46. Alfacalcidol Soft Capsules Price by Application (2019-2024) & (US$/Unit)
• Table 47. Global Alfacalcidol Soft Capsules Price Forecast by Application (2025-2030) & (US$/Unit)
• Table 48. US & Canada Alfacalcidol Soft Capsules Sales by Type (2019-2024) & (K Units)
• Table 49. US & Canada Alfacalcidol Soft Capsules Sales by Type (2025-2030) & (K Units)
• Table 50. US & Canada Alfacalcidol Soft Capsules Revenue by Type (2019-2024) & (US$ Million)
• Table 51. US & Canada Alfacalcidol Soft Capsules Revenue by Type (2025-2030) & (US$ Million)
• Table 52. US & Canada Alfacalcidol Soft Capsules Sales by Application (2019-2024) & (K Units)
• Table 53. US & Canada Alfacalcidol Soft Capsules Sales by Application (2025-2030) & (K Units)
• Table 54. US & Canada Alfacalcidol Soft Capsules Revenue by Application (2019-2024) & (US$ Million)
• Table 55. US & Canada Alfacalcidol Soft Capsules Revenue by Application (2025-2030) & (US$ Million)
• Table 56. US & Canada Alfacalcidol Soft Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 57. US & Canada Alfacalcidol Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
• Table 58. US & Canada Alfacalcidol Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
• Table 59. US & Canada Alfacalcidol Soft Capsules Sales by Country (2019-2024) & (K Units)
• Table 60. US & Canada Alfacalcidol Soft Capsules Sales by Country (2025-2030) & (K Units)
• Table 61. Europe Alfacalcidol Soft Capsules Sales by Type (2019-2024) & (K Units)
• Table 62. Europe Alfacalcidol Soft Capsules Sales by Type (2025-2030) & (K Units)
• Table 63. Europe Alfacalcidol Soft Capsules Revenue by Type (2019-2024) & (US$ Million)
• Table 64. Europe Alfacalcidol Soft Capsules Revenue by Type (2025-2030) & (US$ Million)
• Table 65. Europe Alfacalcidol Soft Capsules Sales by Application (2019-2024) & (K Units)
• Table 66. Europe Alfacalcidol Soft Capsules Sales by Application (2025-2030) & (K Units)
• Table 67. Europe Alfacalcidol Soft Capsules Revenue by Application (2019-2024) & (US$ Million)
• Table 68. Europe Alfacalcidol Soft Capsules Revenue by Application (2025-2030) & (US$ Million)
• Table 69. Europe Alfacalcidol Soft Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 70. Europe Alfacalcidol Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
• Table 71. Europe Alfacalcidol Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
• Table 72. Europe Alfacalcidol Soft Capsules Sales by Country (2019-2024) & (K Units)
• Table 73. Europe Alfacalcidol Soft Capsules Sales by Country (2025-2030) & (K Units)
• Table 74. China Alfacalcidol Soft Capsules Sales by Type (2019-2024) & (K Units)
• Table 75. China Alfacalcidol Soft Capsules Sales by Type (2025-2030) & (K Units)
• Table 76. China Alfacalcidol Soft Capsules Revenue by Type (2019-2024) & (US$ Million)
• Table 77. China Alfacalcidol Soft Capsules Revenue by Type (2025-2030) & (US$ Million)
• Table 78. China Alfacalcidol Soft Capsules Sales by Application (2019-2024) & (K Units)
• Table 79. China Alfacalcidol Soft Capsules Sales by Application (2025-2030) & (K Units)
• Table 80. China Alfacalcidol Soft Capsules Revenue by Application (2019-2024) & (US$ Million)
• Table 81. China Alfacalcidol Soft Capsules Revenue by Application (2025-2030) & (US$ Million)
• Table 82. Asia Alfacalcidol Soft Capsules Sales by Type (2019-2024) & (K Units)
• Table 83. Asia Alfacalcidol Soft Capsules Sales by Type (2025-2030) & (K Units)
• Table 84. Asia Alfacalcidol Soft Capsules Revenue by Type (2019-2024) & (US$ Million)
• Table 85. Asia Alfacalcidol Soft Capsules Revenue by Type (2025-2030) & (US$ Million)
• Table 86. Asia Alfacalcidol Soft Capsules Sales by Application (2019-2024) & (K Units)
• Table 87. Asia Alfacalcidol Soft Capsules Sales by Application (2025-2030) & (K Units)
• Table 88. Asia Alfacalcidol Soft Capsules Revenue by Application (2019-2024) & (US$ Million)
• Table 89. Asia Alfacalcidol Soft Capsules Revenue by Application (2025-2030) & (US$ Million)
• Table 90. Asia Alfacalcidol Soft Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 91. Asia Alfacalcidol Soft Capsules Revenue by Region (2019-2024) & (US$ Million)
• Table 92. Asia Alfacalcidol Soft Capsules Revenue by Region (2025-2030) & (US$ Million)
• Table 93. Asia Alfacalcidol Soft Capsules Sales by Region (2019-2024) & (K Units)
• Table 94. Asia Alfacalcidol Soft Capsules Sales by Region (2025-2030) & (K Units)
• Table 95. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Type (2019-2024) & (K Units)
• Table 96. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Type (2025-2030) & (K Units)
• Table 97. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Type (2019-2024) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Type (2025-2030) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Application (2019-2024) & (K Units)
• Table 100. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Application (2025-2030) & (K Units)
• Table 101. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Application (2019-2024) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Application (2025-2030) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 104. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Country (2019-2024) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue by Country (2025-2030) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Country (2019-2024) & (K Units)
• Table 107. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales by Country (2025-2030) & (K Units)
• Table 108. LEO Pharmaceutical Company Information
• Table 109. LEO Pharmaceutical Description and Major Businesses
• Table 110. LEO Pharmaceutical Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 111. LEO Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. LEO Pharmaceutical Recent Developments
• Table 113. Teva Pharmaceutical Company Information
• Table 114. Teva Pharmaceutical Description and Major Businesses
• Table 115. Teva Pharmaceutical Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 116. Teva Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Teva Pharmaceutical Recent Developments
• Table 118. Teijin Pharma Company Information
• Table 119. Teijin Pharma Description and Major Businesses
• Table 120. Teijin Pharma Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 121. Teijin Pharma Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. Teijin Pharma Recent Developments
• Table 123. Lupin Company Information
• Table 124. Lupin Description and Major Businesses
• Table 125. Lupin Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 126. Lupin Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. Lupin Recent Developments
• Table 128. Nantong Huashan Pharmaceutical Company Information
• Table 129. Nantong Huashan Pharmaceutical Description and Major Businesses
• Table 130. Nantong Huashan Pharmaceutical Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 131. Nantong Huashan Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. Nantong Huashan Pharmaceutical Recent Developments
• Table 133. Xingqun Pharmaceutical Company Information
• Table 134. Xingqun Pharmaceutical Description and Major Businesses
• Table 135. Xingqun Pharmaceutical Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 136. Xingqun Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. Xingqun Pharmaceutical Recent Developments
• Table 138. Shanghai Sine Pharmaceutical Company Information
• Table 139. Shanghai Sine Pharmaceutical Description and Major Businesses
• Table 140. Shanghai Sine Pharmaceutical Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 141. Shanghai Sine Pharmaceutical Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. Shanghai Sine Pharmaceutical Recent Developments
• Table 143. CP Pharmaceutical Qingdao Company Information
• Table 144. CP Pharmaceutical Qingdao Description and Major Businesses
• Table 145. CP Pharmaceutical Qingdao Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 146. CP Pharmaceutical Qingdao Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. CP Pharmaceutical Qingdao Recent Developments
• Table 148. China Res Double-Crane Company Information
• Table 149. China Res Double-Crane Description and Major Businesses
• Table 150. China Res Double-Crane Alfacalcidol Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 151. China Res Double-Crane Alfacalcidol Soft Capsules Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. China Res Double-Crane Recent Developments
• Table 153. Key Raw Materials Lists
• Table 154. Raw Materials Key Suppliers Lists
• Table 155. Alfacalcidol Soft Capsules Distributors List
• Table 156. Alfacalcidol Soft Capsules Customers List
• Table 157. Alfacalcidol Soft Capsules Market Trends
• Table 158. Alfacalcidol Soft Capsules Market Drivers
• Table 159. Alfacalcidol Soft Capsules Market Challenges
• Table 160. Alfacalcidol Soft Capsules Market Restraints
• Table 161. Research Programs/Design for This Report
• Table 162. Key Data Information from Secondary Sources
• Table 163. Key Data Information from Primary Sources

List of Figures

• Figure 1. Alfacalcidol Soft Capsules Product Picture
• Figure 2. Global Alfacalcidol Soft Capsules Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 3. Global Alfacalcidol Soft Capsules Market Share by Type in 2023 & 2030
• Figure 4. 0.25µg Product Picture
• Figure 5. 1µg Product Picture
• Figure 6. Others Product Picture
• Figure 7. Global Alfacalcidol Soft Capsules Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 8. Global Alfacalcidol Soft Capsules Market Share by Application in 2023 & 2030
• Figure 9. Adult
• Figure 10. Child
• Figure 11. Newborn
• Figure 12. Alfacalcidol Soft Capsules Report Years Considered
• Figure 13. Global Alfacalcidol Soft Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
• Figure 14. Global Alfacalcidol Soft Capsules Revenue 2019-2030 (US$ Million)
• Figure 15. Global Alfacalcidol Soft Capsules Revenue Market Share by Region in Percentage: 2023 Versus 2030
• Figure 16. Global Alfacalcidol Soft Capsules Revenue Market Share by Region (2019-2030)
• Figure 17. Global Alfacalcidol Soft Capsules Sales 2019-2030 ((K Units)
• Figure 18. Global Alfacalcidol Soft Capsules Sales Market Share by Region (2019-2030)
• Figure 19. US & Canada Alfacalcidol Soft Capsules Sales YoY (2019-2030) & (K Units)
• Figure 20. US & Canada Alfacalcidol Soft Capsules Revenue YoY (2019-2030) & (US$ Million)
• Figure 21. Europe Alfacalcidol Soft Capsules Sales YoY (2019-2030) & (K Units)
• Figure 22. Europe Alfacalcidol Soft Capsules Revenue YoY (2019-2030) & (US$ Million)
• Figure 23. China Alfacalcidol Soft Capsules Sales YoY (2019-2030) & (K Units)
• Figure 24. China Alfacalcidol Soft Capsules Revenue YoY (2019-2030) & (US$ Million)
• Figure 25. Asia (excluding China) Alfacalcidol Soft Capsules Sales YoY (2019-2030) & (K Units)
• Figure 26. Asia (excluding China) Alfacalcidol Soft Capsules Revenue YoY (2019-2030) & (US$ Million)
• Figure 27. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales YoY (2019-2030) & (K Units)
• Figure 28. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue YoY (2019-2030) & (US$ Million)
• Figure 29. The Alfacalcidol Soft Capsules Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
• Figure 30. The Top 5 and 10 Largest Manufacturers of Alfacalcidol Soft Capsules in the World: Market Share by Alfacalcidol Soft Capsules Revenue in 2023
• Figure 31. Global Alfacalcidol Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
• Figure 32. Global Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• Figure 33. Global Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• Figure 34. Global Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• Figure 35. Global Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• Figure 36. US & Canada Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• Figure 37. US & Canada Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• Figure 38. US & Canada Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• Figure 39. US & Canada Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• Figure 40. US & Canada Alfacalcidol Soft Capsules Revenue Share by Country (2019-2030)
• Figure 41. US & Canada Alfacalcidol Soft Capsules Sales Share by Country (2019-2030)
• Figure 42. U.S. Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 43. Canada Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 44. Europe Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• Figure 45. Europe Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• Figure 46. Europe Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• Figure 47. Europe Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• Figure 48. Europe Alfacalcidol Soft Capsules Revenue Share by Country (2019-2030)
• Figure 49. Europe Alfacalcidol Soft Capsules Sales Share by Country (2019-2030)
• Figure 50. Germany Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 51. France Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 52. U.K. Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 53. Italy Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 54. Netherlands Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 55. China Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• Figure 56. China Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• Figure 57. China Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• Figure 58. China Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• Figure 59. Asia Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• Figure 60. Asia Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• Figure 61. Asia Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• Figure 62. Asia Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• Figure 63. Asia Alfacalcidol Soft Capsules Revenue Share by Region (2019-2030)
• Figure 64. Asia Alfacalcidol Soft Capsules Sales Share by Region (2019-2030)
• Figure 65. Japan Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 66. South Korea Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 67. China Taiwan Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 68. Southeast Asia Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 69. India Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 70. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales Market Share by Type (2019-2030)
• Figure 71. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue Market Share by Type (2019-2030)
• Figure 72. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales Market Share by Application (2019-2030)
• Figure 73. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue Market Share by Application (2019-2030)
• Figure 74. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Revenue Share by Country (2019-2030)
• Figure 75. Middle East, Africa and Latin America Alfacalcidol Soft Capsules Sales Share by Country (2019-2030)
• Figure 76. Brazil Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 77. Mexico Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 78. Turkey Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 79. Israel Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 80. GCC Countries Alfacalcidol Soft Capsules Revenue (2019-2030) & (US$ Million)
• Figure 81. Alfacalcidol Soft Capsules Value Chain
• Figure 82. Alfacalcidol Soft Capsules Production Process
• Figure 83. Channels of Distribution
• Figure 84. Distributors Profiles
• Figure 85. Bottom-up and Top-down Approaches for This Report
• Figure 86. Data Triangulation
• Figure 87. Key Executives Interviewed